FinancialContent

Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

18.90 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
Which stocks are experiencing notable movement on Thursday? ↗
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
Which stocks are moving on Thursday? ↗
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
News headline image
These stocks are gapping in today's session ↗
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
News headline image
The Analyst Verdict: Tandem Diabetes Care In The Eyes Of 4 Experts ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 26, 2025 ↗
 
Via Benzinga
News headline image
Unveiling 8 Analyst Insights On Tandem Diabetes Care ↗
 
Via Benzinga
News headline image
The Analyst Verdict: Tandem Diabetes Care In The Eyes Of 5 Experts ↗
 
Via Benzinga
News headline image
Tandem Diabetes Crashes 32% As Light Outlook Rattles Pump-Maker's Shares ↗
Shares hit their lowest point since January 2024 after the stock market opened Thursday. 
Via Investor's Business Daily
News headline image
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Wondering what's happening in Thursday's pre-market session? Find an overview in this article. 
Via Chartmill
News headline image
These stocks are moving in today's after hours session ↗
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
Tandem Diabetes’s (NASDAQ:TNDM) Q4 Sales Beat Estimates But Stock Drops 12.2%
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 35% year on year to $282.6 million. The company expects next quarter’s... 
Via StockStory
Topics Earnings
News headline image
Analyst Scoreboard: 7 Ratings For Tandem Diabetes Care ↗
 
Via Benzinga
News headline image
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Tandem Diabetes (TNDM) Q4 Earnings: What To Expect
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings tomorrow after the bell. Here’s what to expect. 
Via StockStory
News headline image
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
News headline image
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Tandem Diabetes Care Announces Upcoming Conference Participation
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗
 
Via Benzinga
News headline image
Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says ↗
RBC Capital Markets initiates coverage on Tandem Diabetes Care (TNDM) with an Outperform rating and $65 price target, citing growth opportunities in the U.S. Type 1 and Type 2 diabetes markets, product... 
Via Benzinga
News headline image
Why Tandem Diabetes Care Stock Took It on the Chin Tuesday ↗
Flat revenue growth might be in store for the company in a very crucial market. 
Via The Motley Fool
News headline image
Why Tandem Diabetes Care Stock Thrashed the Market Today ↗
At a stroke, it's got a product authorized for a specific use in 27 countries. 
Via The Motley Fool
News headline image
Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Tandem Diabetes Care Announces Upcoming Conference Participation
From Tandem Diabetes Care, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >